The Value of High-Sensitivity C-reactive Protein in Evaluating Myocardial Damage and the Prognosis in Children with Mycoplasmal Pneumonia

Ann Clin Lab Sci. 2021 Sep;51(5):721-725.

Abstract

Objective: To investigate the value of high-sensitivity C-reactive protein (hs-CRP) in evaluating the myocardial damage and prognosis in children with mycoplasmal pneumonia.

Materials: A total of 150 children with mycoplasmal pneumonia were selected. According to their serum creatine kinase isoenzyme (CK-MB) level, they were divided into 72 cases of the myocardial damage group and 78 cases of the non-myocardial damage group. Eighty healthy children undergoing physical examination were selected as the control group. The electrocardiography results and serum CK-MB and hs-CRP levels were compared among the subjects. The correlations among the above indexes were analyzed.

Results: The levels of hs-CRP and CK-MB in the myocardial damage group were significantly higher than those in the nonmyocardial damage group and control group, respectively (P<0.05). The rates of abnormal hs-CRP and abnormal electrocardiogram in the myocardial damage group were significantly higher than those in the non-myocardial damage group, respectively (P<0.05). In the 150 children with mycoplasmal pneumonia, the serum hs-CRP and CK-MB levels were positively correlated (P<0.001), and the abnormal hs-CRP rate was positively correlated with the abnormal electrocardiogram rate (P<0.001). In the myocardial damage group, the serum levels of hs-CRP and CK-MB after treatment were significantly lower than those before treatment, respectively (P<0.05). After treatment, each index in the myocardial damage group had no significant difference with those in the control group (P>0.05).

Conclusion: hs-CRP may be an important index for evaluating the myocardial damage and prognosis in children with mycoplasmal pneumonia. The combination of hs-CRP and CK-MB detection has obvious guiding significance for the monitoring and treatment of mycoplasmal pneumonia complicated by myocardial damage.

Keywords: children; high-sensitivity C-reactive protein; mycoplasmal pneumonia; myocardial damage.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Biomarkers / analysis
  • C-Reactive Protein / analysis*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Creatine Kinase, MB Form / blood
  • Electrocardiography
  • Erythromycin / therapeutic use
  • Female
  • Humans
  • Male
  • Myocardium / pathology*
  • Pneumonia, Mycoplasma / blood
  • Pneumonia, Mycoplasma / drug therapy
  • Pneumonia, Mycoplasma / physiopathology*
  • Prognosis
  • Sensitivity and Specificity

Substances

  • Anti-Bacterial Agents
  • Biomarkers
  • Erythromycin
  • C-Reactive Protein
  • Creatine Kinase, MB Form